Skip to content

Gastroenteritis in Pediatric Population of Qatar

Epidemiology of Acute Gastroenteritis in the Pediatric Population in Qatar: Causes, Risk Factors, Burden of Disease, Sources and Preventable Measures

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03046342
Acronym
GE
Enrollment
3000
Registered
2017-02-08
Start date
2015-03-10
Completion date
2024-12-10
Last updated
2024-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroenteritis

Keywords

Gastroenteritis, Polymerase chain reaction

Brief summary

Comparison of clinical and laboratory diagnosis for cause of Gastroenteritis(GE) depending on the clinical manifestation.Identifying the sources of viral, bacterial and parasitic GE in Pediatric population of Qatar

Detailed description

Processing of stool samples by molecular method (PCR) for children with GE including complete data collection. Patients are followed up for 14 days

Interventions

DIAGNOSTIC_TESTMolecular method (PCR)

Stool samples are being processed through molecular method (PCR) for children with GE. Epidemiology of acute Gastroenteritis in the pediatric population in Qatar

Sponsors

Hamad Medical Corporation
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Months to 14 Years
Healthy volunteers
No

Inclusion criteria

* All acute gastroenteritis patients between 3 months to 14 years presenting to PEC centers with acute diarrhea+/- vomiting with or without fever

Exclusion criteria

1. Cases of vomiting +/- fever only without diarrhea 2. Suspicion of surgical abdomen 3. Bile stained vomitus 4. Mal-absorption diseases as cystic fibrosis, celiac disease or increased secretion as disaccharides deficiency 5. Cases of Inflammatory bowel disease 6. Antibiotic associated diarrhea 7. Patients with immune deficiency 8. Patients with chronic diarrhea (\>2 weeks of diarrhea) 9. Patients receiving long term medication for any disease

Design outcomes

Primary

MeasureTime frameDescription
sources of viral, bacterial and parasitic GE in the country4 yearsPrevalence of viral, bacterial and parasitic GE in children \< 14 years of age in Qatar will be identified by molecular method sample processing

Secondary

MeasureTime frameDescription
seasonal variation of GE in qatar determination4 yearsseasonal variation of GE in qatar being determined by number of cases reported during each season
comparing the prevalence of viral GE in vaccinated children in Qatar (against rotavirus) and the other countries which implemented rotavirus vaccine4 yearscomparing the prevalence of viral GE in vaccinated children in Qatar (against rotavirus) and the other countries which implemented rotavirus vaccine by detection of source of GE in vaccinated children by molecular method.

Countries

Qatar

Contacts

Primary ContactDr.Khalid Alansari
kalansari1@hamad.qa+974 55336166

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026